National Health Investors (NYSE:NHI) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided EPS guidance of $5.44-5.50 for the period. National Health Investors also updated its FY19 guidance to $5.44-5.50 EPS.
Shares of NHI stock traded up $1.09 during trading hours on Friday, reaching $82.19. 197,654 shares of the company were exchanged, compared to its average volume of 158,400. National Health Investors has a fifty-two week low of $70.54 and a fifty-two week high of $84.57. The business has a fifty day moving average price of $79.42. The firm has a market cap of $3.50 billion, a P/E ratio of 15.00, a price-to-earnings-growth ratio of 3.69 and a beta of 0.37. The company has a debt-to-equity ratio of 0.91, a quick ratio of 14.99 and a current ratio of 14.99.
National Health Investors (NYSE:NHI) last announced its earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.37 by ($0.45). National Health Investors had a return on equity of 11.06% and a net margin of 50.71%. The company had revenue of $78.10 million for the quarter, compared to analyst estimates of $77.64 million. During the same quarter in the previous year, the company posted $1.38 earnings per share. National Health Investors’s revenue for the quarter was up 7.0% on a year-over-year basis. As a group, sell-side analysts predict that National Health Investors will post 5.49 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Monday, September 30th will be given a dividend of $1.05 per share. The ex-dividend date is Friday, September 27th. This represents a $4.20 dividend on an annualized basis and a dividend yield of 5.11%. National Health Investors’s payout ratio is 76.64%.
Separately, Zacks Investment Research upgraded shares of National Health Investors from a hold rating to a buy rating and set a $90.00 target price on the stock in a research report on Tuesday, August 6th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. National Health Investors currently has an average rating of Hold and an average price target of $79.60.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Story: How Does the Quiet Period Work?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.